PLUS THERAPEUTICS INC (PSTV) Fundamental Analysis & Valuation

NASDAQ:PSTV • US72941H5090

Current stock price

7.62 USD
+0.48 (+6.72%)
At close:
7.419 USD
-0.2 (-2.64%)
After Hours:

This PSTV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. PSTV Profitability Analysis

1.1 Basic Checks

  • PSTV had negative earnings in the past year.
  • PSTV had a negative operating cash flow in the past year.
  • PSTV had negative earnings in each of the past 5 years.
  • In the past 5 years PSTV always reported negative operating cash flow.
PSTV Yearly Net Income VS EBIT VS OCF VS FCFPSTV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -5M -10M -15M -20M -25M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -137.13%, PSTV is doing worse than 81.59% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -560.21%, PSTV is doing worse than 77.91% of the companies in the same industry.
Industry RankSector Rank
ROA -137.13%
ROE -560.21%
ROIC N/A
ROA(3y)-149.9%
ROA(5y)-119.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
PSTV Yearly ROA, ROE, ROICPSTV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500 -500

1.3 Margins

  • PSTV does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PSTV Yearly Profit, Operating, Gross MarginsPSTV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. PSTV Health Analysis

2.1 Basic Checks

  • PSTV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, PSTV has more shares outstanding
  • Compared to 5 years ago, PSTV has more shares outstanding
  • Compared to 1 year ago, PSTV has an improved debt to assets ratio.
PSTV Yearly Shares OutstandingPSTV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M
PSTV Yearly Total Debt VS Total AssetsPSTV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -44.42, we must say that PSTV is in the distress zone and has some risk of bankruptcy.
  • PSTV's Altman-Z score of -44.42 is on the low side compared to the rest of the industry. PSTV is outperformed by 91.47% of its industry peers.
  • PSTV has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of PSTV (0.19) is worse than 66.09% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z -44.42
ROIC/WACCN/A
WACC9.49%
PSTV Yearly LT Debt VS Equity VS FCFPSTV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M -20M

2.3 Liquidity

  • PSTV has a Current Ratio of 1.23. This is a normal value and indicates that PSTV is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.23, PSTV is doing worse than 84.69% of the companies in the same industry.
  • A Quick Ratio of 1.23 indicates that PSTV should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.23, PSTV is doing worse than 83.91% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.23
PSTV Yearly Current Assets VS Current LiabilitesPSTV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. PSTV Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 42.33% over the past year.
  • The Revenue for PSTV has decreased by -10.49% in the past year. This is quite bad
  • PSTV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 77.01% yearly.
EPS 1Y (TTM)42.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.53%
Revenue 1Y (TTM)-10.49%
Revenue growth 3Y187.23%
Revenue growth 5Y77.01%
Sales Q2Q%-3.19%

3.2 Future

  • Based on estimates for the next years, PSTV will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.00% on average per year.
  • PSTV is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 103.16% yearly.
EPS Next Y88.18%
EPS Next 2Y38.95%
EPS Next 3Y25.48%
EPS Next 5Y15%
Revenue Next Year8.67%
Revenue Next 2Y98.2%
Revenue Next 3Y107.75%
Revenue Next 5Y103.16%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
PSTV Yearly Revenue VS EstimatesPSTV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
PSTV Yearly EPS VS EstimatesPSTV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -5M -10M -15M -20M -25M

More info and screens

Find the best growth stocksShow best growing peers

1

4. PSTV Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for PSTV. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for PSTV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PSTV Price Earnings VS Forward Price EarningsPSTV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PSTV Per share dataPSTV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30

4.3 Compensation for Growth

  • A more expensive valuation may be justified as PSTV's earnings are expected to grow with 25.48% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.95%
EPS Next 3Y25.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. PSTV Dividend Analysis

5.1 Amount

  • No dividends for PSTV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PSTV Fundamentals: All Metrics, Ratios and Statistics

PLUS THERAPEUTICS INC

NASDAQ:PSTV (4/22/2026, 5:39:32 PM)

After market: 7.419 -0.2 (-2.64%)

7.62

+0.48 (+6.72%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-12
Earnings (Next)05-28
Inst Owners14.02%
Inst Owner Change0%
Ins Owners0.53%
Ins Owner Change22.04%
Market Cap52.27M
Revenue(TTM)5.21M
Net Income(TTM)-22.39M
Analysts80
Price Target140.15 (1739.24%)
Short Float %N/A
Short Ratio4.49
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-60.62%
Min EPS beat(2)-96.08%
Max EPS beat(2)-25.16%
EPS beat(4)1
Avg EPS beat(4)-173.72%
Min EPS beat(4)-695.44%
Max EPS beat(4)121.79%
EPS beat(8)4
Avg EPS beat(8)-78.39%
EPS beat(12)7
Avg EPS beat(12)-44.15%
EPS beat(16)9
Avg EPS beat(16)-31.88%
Revenue beat(2)1
Avg Revenue beat(2)-2.21%
Min Revenue beat(2)-8.69%
Max Revenue beat(2)4.27%
Revenue beat(4)1
Avg Revenue beat(4)-10.68%
Min Revenue beat(4)-30.01%
Max Revenue beat(4)4.27%
Revenue beat(8)2
Avg Revenue beat(8)-4.86%
Revenue beat(12)4
Avg Revenue beat(12)6.15%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2228.81%
PT rev (3m)1672.9%
EPS NQ rev (1m)-2534.26%
EPS NQ rev (3m)-2095%
EPS NY rev (1m)-2064.18%
EPS NY rev (3m)-2119.43%
Revenue NQ rev (1m)-20.01%
Revenue NQ rev (3m)-36.15%
Revenue NY rev (1m)-7.16%
Revenue NY rev (3m)-11.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 10.03
P/FCF N/A
P/OCF N/A
P/B 13.08
P/tB 15.88
EV/EBITDA N/A
EPS(TTM)-31.29
EYN/A
EPS(NY)-3.7
Fwd EYN/A
FCF(TTM)-3.04
FCFYN/A
OCF(TTM)-3.03
OCFYN/A
SpS0.76
BVpS0.58
TBVpS0.48
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -137.13%
ROE -560.21%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-149.9%
ROA(5y)-119.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.06%
Cap/Sales 1.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.23
Altman-Z -44.42
F-Score4
WACC9.49%
ROIC/WACCN/A
Cap/Depr(3y)45.37%
Cap/Depr(5y)50.67%
Cap/Sales(3y)5.47%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%91.53%
EPS Next Y88.18%
EPS Next 2Y38.95%
EPS Next 3Y25.48%
EPS Next 5Y15%
Revenue 1Y (TTM)-10.49%
Revenue growth 3Y187.23%
Revenue growth 5Y77.01%
Sales Q2Q%-3.19%
Revenue Next Year8.67%
Revenue Next 2Y98.2%
Revenue Next 3Y107.75%
Revenue Next 5Y103.16%
EBIT growth 1Y-4.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2.26%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-85.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-96.84%
OCF growth 3YN/A
OCF growth 5YN/A

PLUS THERAPEUTICS INC / PSTV Fundamental Analysis FAQ

What is the fundamental rating for PSTV stock?

ChartMill assigns a fundamental rating of 2 / 10 to PSTV.


What is the valuation status of PLUS THERAPEUTICS INC (PSTV) stock?

ChartMill assigns a valuation rating of 1 / 10 to PLUS THERAPEUTICS INC (PSTV). This can be considered as Overvalued.


Can you provide the profitability details for PLUS THERAPEUTICS INC?

PLUS THERAPEUTICS INC (PSTV) has a profitability rating of 0 / 10.


How sustainable is the dividend of PLUS THERAPEUTICS INC (PSTV) stock?

The dividend rating of PLUS THERAPEUTICS INC (PSTV) is 0 / 10 and the dividend payout ratio is 0%.